Exact Mass: 776.6682

Thyroxine

C15H11I4NO4 (776.6867)

Thyroxine (3,5,3‚Ä≤,5‚Ä≤-tetraiodothyronine) or T4 is one of two major hormones derived from the thyroid gland, the other being triiodothyronine (T3). The major form of thyroid hormone in the blood is thyroxine (T4), which has a longer half-life than T3. In humans, the ratio of T4 to T3 released into the blood is approximately 14:1. T4 is converted to the active T3 (three to four times more potent than T4) within cells by enzymes known as deiodinases (5‚Ä≤-iodinase). Thyroxine is synthesized via the iodination of tyrosines (monoiodotyrosine) and the coupling of iodotyrosines (diiodotyrosine) in the thyroglobulin. Iodine is critical to the synthesis of thyroxine and other thyroid hormones. Through a reaction with the enzyme thyroperoxidase, iodine is covalently bound to tyrosine residues found in the thyroglobulin protein, forming monoiodotyrosine (MIT) and diiodotyrosine (DIT). Linking two moieties of DIT produces thyroxine. Combining one molecule of MIT and one molecule of DIT produces triiodothyronine. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Iodide is actively absorbed from the bloodstream and concentrated in the thyroid follicles where thyroxine is produced. If there is a deficiency of dietary iodine, the thyroid enlarges in an attempt to trap more iodine, resulting in a condition called goitre. More specifically, the lack of thyroid hormones will lead to decreased negative feedback on the pituitary gland, leading to increased production of thyroid-stimulating hormone, which causes the thyroid to enlarge, leading to goitre. Thyroxine can be peripherally de-iodinated to form triiodothyronine which exerts a broad spectrum of stimulatory effects on cell metabolism. Thyroid hormones function via a well-studied set of nuclear receptors, termed the thyroid hormone receptors. They act on nearly every cell in the body. In particular, thyroid hormones act to increase the basal metabolic rate, affect protein synthesis, help regulate long bone growth (synergy with growth hormone) and neural maturation, and increase the bodys sensitivity to catecholamines (such as adrenaline) by permissiveness. The thyroid hormones are essential to proper development and differentiation of all cells of the human body. These hormones also regulate protein, fat, and carbohydrate metabolism, affecting how human cells use energetic compounds. They also stimulate vitamin metabolism. Numerous physiological and pathological stimuli influence thyroid hormone synthesis. Levothyroxine, a manufactured form of thyroxine, was the most prescribed medication in the United States with more than 114 million prescriptions. Thyroxine, one of the two major hormones secreted by the thyroid gland (the other is triiodothyronine). Thyroxine’s principal function is to stimulate the consumption of oxygen and thus the metabolism of all cells and tissues in the body. Thyroxine is formed by the molecular addition of iodine to the amino acid tyrosine while the latter is bound to the protein thyroglobulin. Excessive secretion of thyroxine in the body is known as hyperthyroidism, and the deficient secretion of it is called hypothyroidism. Thyroid hormones are any hormones produced and released by the thyroid gland, namely triiodothyronine (T3) and thyroxine (T4). They are tyrosine-based hormones that are primarily responsible for regulation of metabolism. T3 and T4 are partially composed of iodine, derived from food.[2] A deficiency of iodine leads to decreased production of T3 and T4, enlarges the thyroid tissue and will cause the disease known as simple goitre.[3] The major form of thyroid hormone in the blood is thyroxine (T4), whose half-life of around one week[4] is longer than that of T3.[5] In humans, the ratio of T4 to T3 released into the blood is approximately 14:1.[6] T4 is converted to the active T3 (three to four times more potent than T4) within cells by deiodinases (5′-deiodinase). These are further processed by decarboxylation and deiodination to produce iodothyronamine (T1a) and thyronamine (T0a). All three isoforms of the deiodinases are selenium-containing enzymes, thus dietary selenium is essential for T3 production. The thyroid hormone is one of the factors responsible for the modulation of energy expenditure. This is achieved through several mechanisms, such as mitochondrial biogenesis, adaptive thermogenesis, etc.[7] American chemist Edward Calvin Kendall was responsible for the isolation of thyroxine in 1915.[8] In 2020, levothyroxine, a manufactured form of thyroxine, was the second most commonly prescribed medication in the United States, with more than 98 million prescriptions.[9][10] Levothyroxine is on the World Health Organization's List of Essential Medicines.[11] (-)-Thyroxine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=7488-70-2 (retrieved 2024-06-28) (CAS RN: 51-48-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). D-Thyroxine (D-T4) is a thyroid hormone that can inhibit TSH secretion. D-Thyroxine can be used for the research of hypercholesterolemia[1][2]. L-Thyroxine (Levothyroxine; T4) is a synthetic hormone for the research of hypothyroidism. DIO enzymes convert biologically active thyroid hormone (Triiodothyronine,T3) from L-Thyroxine (T4)[1].

TG(14:0/16:1(9Z)/16:0)

C49H92O6 (776.6894)

TG(14:0/16:1(9Z)/16:0) is a monopalmitoleic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:0/16:1(9Z)/16:0), in particular, consists of one chain of myristic acid at the C-1 position, one chain of palmitoleic acid at the C-2 position and one chain of palmitic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(16:0/14:0/16:1(9Z))

C49H92O6 (776.6894)

TG(16:0/14:0/16:1(9Z))[iso6] is a monopalmitic acid triglyceride. Triglycerides (TGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid tri-esters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:0/14:0/16:1(9Z))[iso6], in particular, consists of one chain of palmitic acid at the C-1 position, one chain of myristic acid at the C-2 position and one chain of palmitoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols. TG(16:0/14:0/16:1(9Z))[iso6] is a monopalmitic acid triglyceride. Triglycerides (TGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid tri-esters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:0/14:0/16:1(9Z))[iso6], in particular, consists of one chain of palmitic acid at the C-1 position, one chain of myristic acid at the C-2 position and one chain of palmitoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)

Dextrothyroxine

C15H11I4NO4 (776.6867)

The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (monoiodotyrosine) and the coupling of iodotyrosines (diiodotyrosine) in the thyroglobulin. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form triiodothyronine which exerts a broad spectrum of stimulatory effects on cell metabolism. [PubChem] C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1553 - Thyroid Agent D-Thyroxine (D-T4) is a thyroid hormone that can inhibit TSH secretion. D-Thyroxine can be used for the research of hypercholesterolemia[1][2].

Glycerol 1,3-ditetradecanoate 2-(9Z-octadecenoate)

C49H92O6 (776.6894)

Glycerol 1,3-ditetradecanoate 2-(9Z-octadecenoate) is found in fats and oils. Glycerol 1,3-ditetradecanoate 2-(9Z-octadecenoate) is a minor component of sunflower and other vegetable oil Minor component of sunflower and other vegetable oils. Glycerol 1,3-ditetradecanoate 2-(9Z-octadecenoate) is found in fats and oils.

TG(14:0/14:0/18:1(11Z))

C49H92O6 (776.6894)

TG(14:0/14:0/18:1(11Z)) is a dimyristic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:0/14:0/18:1(11Z)), in particular, consists of one chain of myristic acid at the C-1 position, one chain of myristic acid at the C-2 position and one chain of vaccenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(14:0/14:0/18:1(9Z))

C49H92O6 (776.6894)

TG(14:0/14:0/18:1(9Z)) is a dimyristic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:0/14:0/18:1(9Z)), in particular, consists of one chain of myristic acid at the C-1 position, one chain of myristic acid at the C-2 position and one chain of oleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(14:0/16:0/16:1(9Z))

C49H92O6 (776.6894)

TG(14:0/16:0/16:1(9Z)) is a monopalmitic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:0/16:0/16:1(9Z)), in particular, consists of one chain of myristic acid at the C-1 position, one chain of palmitic acid at the C-2 position and one chain of palmitoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(14:0/18:0/14:1(9Z))

C49H92O6 (776.6894)

TG(14:0/18:0/14:1(9Z)) is a monostearic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:0/18:0/14:1(9Z)), in particular, consists of one chain of myristic acid at the C-1 position, one chain of stearic acid at the C-2 position and one chain of myristoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(14:0/14:1(9Z)/18:0)

C49H92O6 (776.6894)

TG(14:0/14:1(9Z)/18:0) is a monostearic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:0/14:1(9Z)/18:0), in particular, consists of one chain of myristic acid at the C-1 position, one chain of myristoleic acid at the C-2 position and one chain of stearic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(14:0/18:1(11Z)/14:0)

C49H92O6 (776.6894)

TG(14:0/18:1(11Z)/14:0) is a dimyristic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:0/18:1(11Z)/14:0), in particular, consists of one chain of myristic acid at the C-1 position, one chain of vaccenic acid at the C-2 position and one chain of myristic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(14:0/18:1(9Z)/14:0)

C49H92O6 (776.6894)

TG(14:0/18:1(9Z)/14:0) is a dimyristic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:0/18:1(9Z)/14:0), in particular, consists of one chain of myristic acid at the C-1 position, one chain of oleic acid at the C-2 position and one chain of myristic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/15:0/16:1(9Z))

C49H92O6 (776.6894)

TG(15:0/15:0/16:1(9Z)) is a dipentadecanoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/15:0/16:1(9Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of palmitoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/16:1(9Z)/15:0)

C49H92O6 (776.6894)

TG(15:0/16:1(9Z)/15:0) is a dipentadecanoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/16:1(9Z)/15:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of palmitoleic acid at the C-2 position and one chain of pentadecanoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(16:0/16:0/14:1(9Z))

C49H92O6 (776.6894)

TG(16:0/16:0/14:1(9Z)) is a dipalmitic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:0/16:0/14:1(9Z)), in particular, consists of one chain of palmitic acid at the C-1 position, one chain of palmitic acid at the C-2 position and one chain of myristoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(16:0/14:1(9Z)/16:0)

C49H92O6 (776.6894)

TG(16:0/14:1(9Z)/16:0) is a dipalmitic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:0/14:1(9Z)/16:0), in particular, consists of one chain of palmitic acid at the C-1 position, one chain of myristoleic acid at the C-2 position and one chain of palmitic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(18:0/14:0/14:1(9Z))

C49H92O6 (776.6894)

TG(18:0/14:0/14:1(9Z)) is a monostearic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/14:0/14:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position, one chain of myristic acid at the C-2 position and one chain of myristoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

(2S)-2-(Diiodoamino)-3-[4-(4-hydroxyphenoxy)phenyl]-2,3-diiodopropanoic acid

C15H11I4NO4 (776.6867)

DG(a-25:0/20:3(8Z,11Z,14Z)-2OH(5,6)/0:0)

C48H88O7 (776.653)

DG(a-25:0/20:3(8Z,11Z,14Z)-2OH(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-25:0/20:3(8Z,11Z,14Z)-2OH(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-2OH(5,6)/a-25:0/0:0)

C48H88O7 (776.653)

DG(20:3(8Z,11Z,14Z)-2OH(5,6)/a-25:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-2OH(5,6)/a-25:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-25:0/0:0/20:3(8Z,11Z,14Z)-2OH(5,6))

C48H88O7 (776.653)

DG(a-25:0/0:0/20:3(8Z,11Z,14Z)-2OH(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-2OH(5,6)/0:0/a-25:0)

C48H88O7 (776.653)

DG(20:3(8Z,11Z,14Z)-2OH(5,6)/0:0/a-25:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Triacylglycerol 12:0-16:0-18:1

C49H92O6 (776.6894)

Thyroxine - CASMI2016 Category 1 - Challenge 17

C15H11I4NO4 (776.6867)

L-thyroxine

C15H11I4NO4 (776.6867)

The L-enantiomer of thyroxine. CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 8522 D-Thyroxine (D-T4) is a thyroid hormone that can inhibit TSH secretion. D-Thyroxine can be used for the research of hypercholesterolemia[1][2].

Thyroxine

C15H11I4NO4 (776.6867)

L-Thyroxine (Levothyroxine; T4) is a synthetic hormone for the research of hypothyroidism. DIO enzymes convert biologically active thyroid hormone (Triiodothyronine,T3) from L-Thyroxine (T4)[1].

TG(14:0/15:0/17:1(9Z))[iso6]

C49H92O6 (776.6894)

TG(14:0/15:1(9Z)/17:0)[iso6]

C49H92O6 (776.6894)

TG(14:0/16:0/16:1(9Z))[iso6]

C49H92O6 (776.6894)

TG(14:1(9Z)/15:0/17:0)[iso6]

C49H92O6 (776.6894)

TG(15:0/15:1(9Z)/16:0)[iso6]

C49H92O6 (776.6894)

Triglyceride

C49H92O6 (776.6894)

D-Thyroxine

C15H11I4NO4 (776.6867)

The D-enantiomer of thyroxine. D-Thyroxine (D-T4) is a thyroid hormone that can inhibit TSH secretion. D-Thyroxine can be used for the research of hypercholesterolemia[1][2].

5-Ethylbarbituric acid

C49H92O6 (776.6894)

TG(12:0/12:0/22:1(11Z))[iso3]

C49H92O6 (776.6894)

TG(13:0/13:0/20:1(11Z))[iso3]

C49H92O6 (776.6894)

TG(14:0/14:0/18:1(9Z))[iso3]

C49H92O6 (776.6894)

TG(14:1(9Z)/16:0/16:0)[iso3]

C49H92O6 (776.6894)

TG(15:0/15:0/16:1(9Z))[iso3]

C49H92O6 (776.6894)

TG(12:0/14:0/20:1(11Z))[iso6]

C49H92O6 (776.6894)

TG(12:0/14:1(9Z)/20:0)[iso6]

C49H92O6 (776.6894)

TG(12:0/15:0/19:1(9Z))[iso6]

C49H92O6 (776.6894)

TG(12:0/15:1(9Z)/19:0)[iso6]

C49H92O6 (776.6894)

TG(12:0/16:0/18:1(9Z))[iso6]

C49H92O6 (776.6894)

TG(12:0/16:1(9Z)/18:0)[iso6]

C49H92O6 (776.6894)

TG(12:0/17:0/17:1(9Z))[iso6]

C49H92O6 (776.6894)

TG(13:0/14:0/19:1(9Z))[iso6]

C49H92O6 (776.6894)

TG(13:0/14:1(9Z)/19:0)[iso6]

C49H92O6 (776.6894)

TG(13:0/15:0/18:1(9Z))[iso6]

C49H92O6 (776.6894)

TG(13:0/15:1(9Z)/18:0)[iso6]

C49H92O6 (776.6894)

TG(13:0/16:0/17:1(9Z))[iso6]

C49H92O6 (776.6894)

TG(13:0/16:1(9Z)/17:0)[iso6]

C49H92O6 (776.6894)

TG(14:0/14:1(9Z)/18:0)[iso6]

C49H92O6 (776.6894)

TG 46:1

C49H92O6 (776.6894)

1-Lauroyl-2-Oleoyl-3-Palmitoyl-rac-glycerol

C49H92O6 (776.6894)

Thyroxine I-125

C15H11I4NO4 (776.6867)

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1553 - Thyroid Agent

Thyroxine I 131

C15H11I4NO4 (776.6867)

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1553 - Thyroid Agent

Levothyroxine

C15H11I4NO4 (776.6867)

H - Systemic hormonal preparations, excl. sex hormones and insulins > H03 - Thyroid therapy > H03A - Thyroid preparations > H03AA - Thyroid hormones D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1553 - Thyroid Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS The thyronamines function via some unknown mechanism to inhibit neuronal activity; this plays an important role in the hibernation cycles of mammals. One effect of administering the thyronamines is a severe drop in body temperature.; Iodide is actively absorbed from the bloodstream and concentrated in the thyroid follicles. (If there is a deficiency of dietary iodine, the thyroid enlarges in an attempt to trap more iodine, resulting in goitre.) Via a reaction with the enzyme thyroperoxidase, iodine is covalently bound to tyrosine residues in the thyroglobulin molecules, forming monoiodotyrosine (MIT) and diiodotyrosine (DIT). Linking two moieties of DIT produces thyroxine. Combining one particle of MIT and one particle of DIT produces triiodothyronine.; Both T3 and T4 are used to treat thyroid hormone deficiency (hypothyroidism). They are both absorbed well by the gut, so can be given orally. Levothyroxine, the most commonly used synthetic thyroxine form, is a stereoisomer of physiological thyroxine, which is metabolized more slowly and hence usually only needs once-daily administration. Natural desiccated thyroid hormones, which are derived from pig thyroid glands, are a "natural" hypothyroid treatment containing 20\\\% T3 and traces of T2, T1 and calcitonin.; this plays an important role in the hibernation cycles of mammals. One effect of administering the thyronamines is a severe drop in body temperature.; The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (monoiodotyrosine) and the coupling of iodotyrosines (diiodotyrosine) in the thyroglobulin. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form triiodothyronine which exerts a broad spectrum of stimulatory effects on cell metabolism.; The thyronamines function via some unknown mechanism to inhibit neuronal activity [HMDB] L-Thyroxine (Levothyroxine; T4) is a synthetic hormone for the research of hypothyroidism. DIO enzymes convert biologically active thyroid hormone (Triiodothyronine,T3) from L-Thyroxine (T4)[1].

(2S)-2-ammonio-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate

C15H11I4NO4 (776.6867)

2-Amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-propionate

C15H11I4NO4 (776.6867)

(2R)-2-azaniumyl-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate

C15H11I4NO4 (776.6867)

1-Pentadecanoyl-2-palmitoleoyl-3-pentadecanoyl-glycerol

C49H92O6 (776.6894)

1-Palmitoyl-2-myristoyl-3-palmitoleoyl-glycerol

C49H92O6 (776.6894)

2-[[(2R)-3-hexadecoxy-2-icosanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

(2S)-2-(Diiodoamino)-3-[4-(4-hydroxyphenoxy)phenyl]-2,3-diiodopropanoic acid

C15H11I4NO4 (776.6867)

2-[hydroxy-[(2R)-2-octadecanoyloxy-3-octadecoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

DG(a-25:0/20:3(8Z,11Z,14Z)-2OH(5,6)/0:0)

C48H88O7 (776.653)

DG(20:3(8Z,11Z,14Z)-2OH(5,6)/a-25:0/0:0)

C48H88O7 (776.653)

DG(a-25:0/0:0/20:3(8Z,11Z,14Z)-2OH(5,6))

C48H88O7 (776.653)

DG(20:3(8Z,11Z,14Z)-2OH(5,6)/0:0/a-25:0)

C48H88O7 (776.653)

N-henicosanoyl-4-hydroxy-15-methylhexadecasphinganine-1-phosphocholine

C43H89N2O7P (776.6407)

1,2-Dimyristoyl-3-oleoyl glycerol

C49H92O6 (776.6894)

NAGlySer 24:2/17:0

C46H84N2O7 (776.6278)

NAGlySer 17:0/24:2

C46H84N2O7 (776.6278)

NAGlySer 19:1/22:1

C46H84N2O7 (776.6278)

NAGlySer 19:2/22:0

C46H84N2O7 (776.6278)

NAGlySer 21:1/20:1

C46H84N2O7 (776.6278)

NAGlySer 25:0/16:2

C46H84N2O7 (776.6278)

NAOrn 20:1/23:0

C48H92N2O5 (776.7006)

NAOrn 17:0/26:1

C48H92N2O5 (776.7006)

NAOrn 23:0/20:1

C48H92N2O5 (776.7006)

NAOrn 26:1/17:0

C48H92N2O5 (776.7006)

NAOrn 25:0/18:1

C48H92N2O5 (776.7006)

NAOrn 26:0/17:1

C48H92N2O5 (776.7006)

NAOrn 21:1/22:0

C48H92N2O5 (776.7006)

NAOrn 22:1/21:0

C48H92N2O5 (776.7006)

NAOrn 24:0/19:1

C48H92N2O5 (776.7006)

NAOrn 18:1/25:0

C48H92N2O5 (776.7006)

NAOrn 24:1/19:0

C48H92N2O5 (776.7006)

NAOrn 19:1/24:0

C48H92N2O5 (776.7006)

NAOrn 19:0/24:1

C48H92N2O5 (776.7006)

NAOrn 22:0/21:1

C48H92N2O5 (776.7006)

NAOrn 17:1/26:0

C48H92N2O5 (776.7006)

NAOrn 21:0/22:1

C48H92N2O5 (776.7006)

[3,4-Dihydroxy-2-(icosanoylamino)octadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C43H89N2O7P (776.6407)

PE-Cer 23:0;2O/18:0;O

C43H89N2O7P (776.6407)

PE-Cer 18:0;2O/23:0;O

C43H89N2O7P (776.6407)

PE-Cer 15:0;2O/26:0;O

C43H89N2O7P (776.6407)

PE-Cer 16:0;2O/25:0;O

C43H89N2O7P (776.6407)

PE-Cer 19:0;2O/22:0;O

C43H89N2O7P (776.6407)

PE-Cer 26:0;2O/15:0;O

C43H89N2O7P (776.6407)

PE-Cer 22:0;2O/19:0;O

C43H89N2O7P (776.6407)

PE-Cer 20:0;2O/21:0;O

C43H89N2O7P (776.6407)

PE-Cer 21:0;2O/20:0;O

C43H89N2O7P (776.6407)

PE-Cer 25:0;2O/16:0;O

C43H89N2O7P (776.6407)

PE-Cer 24:0;2O/17:0;O

C43H89N2O7P (776.6407)

PE-Cer 17:0;2O/24:0;O

C43H89N2O7P (776.6407)

[1-hydroxy-3-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoxy]propan-2-yl] (Z)-henicos-11-enoate

C52H88O4 (776.6682)

[1-[(Z)-henicos-11-enoxy]-3-hydroxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoate

C52H88O4 (776.6682)

[1-[(11Z,14Z)-henicosa-11,14-dienoxy]-3-hydroxypropan-2-yl] (10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoate

C52H88O4 (776.6682)

[1-hydroxy-3-[(10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoxy]propan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C52H88O4 (776.6682)

(1-hydroxy-3-octanoyloxypropan-2-yl) (16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-tetraconta-16,19,22,25,28,31,34,37-octaenoate

C51H84O5 (776.6318)

[3-hydroxy-2-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxypropyl] (13Z,16Z)-tetracosa-13,16-dienoate

C51H84O5 (776.6318)

[1-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-hydroxypropan-2-yl] (8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoate

C51H84O5 (776.6318)

[3-hydroxy-2-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxypropyl] (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate

C51H84O5 (776.6318)

[1-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropan-2-yl] (12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-12,15,18,21,24,27-hexaenoate

C51H84O5 (776.6318)

[1-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropan-2-yl] (15Z,18Z,21Z,24Z,27Z)-triaconta-15,18,21,24,27-pentaenoate

C51H84O5 (776.6318)

[3-hydroxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropyl] (14Z,17Z,20Z)-octacosa-14,17,20-trienoate

C51H84O5 (776.6318)

(1-decanoyloxy-3-hydroxypropan-2-yl) (14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-octatriaconta-14,17,20,23,26,29,32,35-octaenoate

C51H84O5 (776.6318)

[1-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-hydroxypropan-2-yl] (14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-14,17,20,23,26,29-hexaenoate

C51H84O5 (776.6318)

[1-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropan-2-yl] (10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoate

C51H84O5 (776.6318)

[1-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-hydroxypropan-2-yl] (11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoate

C51H84O5 (776.6318)

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-hydroxypropan-2-yl] (17Z,20Z,23Z,26Z,29Z)-dotriaconta-17,20,23,26,29-pentaenoate

C51H84O5 (776.6318)

[1-hydroxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropan-2-yl] (18Z,21Z,24Z,27Z)-triaconta-18,21,24,27-tetraenoate

C51H84O5 (776.6318)

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (20Z,23Z,26Z,29Z)-dotriaconta-20,23,26,29-tetraenoate

C51H84O5 (776.6318)

(1-dodecanoyloxy-3-hydroxypropan-2-yl) (12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-12,15,18,21,24,27,30,33-octaenoate

C51H84O5 (776.6318)

(1-hydroxy-3-octadecanoyloxypropan-2-yl) (6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-6,9,12,15,18,21,24,27-octaenoate

C51H84O5 (776.6318)

[1-hydroxy-3-[(Z)-octadec-9-enoyl]oxypropan-2-yl] (9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-9,12,15,18,21,24,27-heptaenoate

C51H84O5 (776.6318)

[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-hydroxypropyl] (12Z,15Z,18Z)-hexacosa-12,15,18-trienoate

C51H84O5 (776.6318)

(1-hexadecanoyloxy-3-hydroxypropan-2-yl) (8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-8,11,14,17,20,23,26,29-octaenoate

C51H84O5 (776.6318)

[1-hydroxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropan-2-yl] (13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoate

C51H84O5 (776.6318)

(1-hydroxy-3-tetradecanoyloxypropan-2-yl) (10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-10,13,16,19,22,25,28,31-octaenoate

C51H84O5 (776.6318)

[3-hydroxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropyl] (16Z,19Z,22Z)-triaconta-16,19,22-trienoate

C51H84O5 (776.6318)

[1-hydroxy-3-[(Z)-icos-11-enoyl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoate

C51H84O5 (776.6318)

[1-hydroxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropan-2-yl] (16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoate

C51H84O5 (776.6318)

[1-[(Z)-docos-13-enoyl]oxy-3-hydroxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoate

C51H84O5 (776.6318)

[1-hydroxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-13,16,19,22,25,28,31-heptaenoate

C51H84O5 (776.6318)

[1-[(Z)-hexadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-11,14,17,20,23,26,29-heptaenoate

C51H84O5 (776.6318)

[3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoxy]-2-octanoyloxypropyl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C51H84O5 (776.6318)

[1-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-octoxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C51H84O5 (776.6318)

2,3-di(nonanoyloxy)propyl (Z)-octacos-17-enoate

C49H92O6 (776.6894)

2,3-di(octanoyloxy)propyl (Z)-triacont-19-enoate

C49H92O6 (776.6894)

[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-octoxypropyl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C51H84O5 (776.6318)

[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-octoxypropyl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C51H84O5 (776.6318)

[3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]-2-octanoyloxypropyl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C51H84O5 (776.6318)

[3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-octanoyloxypropyl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C51H84O5 (776.6318)

[3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]-2-octanoyloxypropyl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C51H84O5 (776.6318)

[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]-2-octanoyloxypropyl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C51H84O5 (776.6318)

[3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]-2-octanoyloxypropyl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C51H84O5 (776.6318)

[2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxy-3-octoxypropyl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C51H84O5 (776.6318)

[3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]-2-octanoyloxypropyl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C51H84O5 (776.6318)

[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-2-octanoyloxypropyl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C51H84O5 (776.6318)

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-octoxypropyl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C51H84O5 (776.6318)

[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-octoxypropyl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C51H84O5 (776.6318)

[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-2-octanoyloxypropyl] (9Z,12Z)-octadeca-9,12-dienoate

C51H84O5 (776.6318)

[3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoxy]-2-octanoyloxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C51H84O5 (776.6318)

[3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]-2-octanoyloxypropyl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C51H84O5 (776.6318)

[2-decanoyloxy-3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoxy]propyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C51H84O5 (776.6318)

[3-nonanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] docosanoate

C49H92O6 (776.6894)

(3-nonanoyloxy-2-octadecanoyloxypropyl) (Z)-nonadec-9-enoate

C49H92O6 (776.6894)

[3-decoxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C51H84O5 (776.6318)

[3-decoxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropyl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C51H84O5 (776.6318)

[2-[(Z)-hexadec-9-enoyl]oxy-3-octanoyloxypropyl] docosanoate

C49H92O6 (776.6894)

[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-tetradecanoyloxypropyl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C51H84O5 (776.6318)

[2-dodecanoyloxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propyl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C51H84O5 (776.6318)

[2-[(Z)-heptadec-9-enoyl]oxy-3-nonanoyloxypropyl] icosanoate

C49H92O6 (776.6894)

[3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]-2-tetradecanoyloxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C51H84O5 (776.6318)

[3-dodecoxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropyl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C51H84O5 (776.6318)

[2-decanoyloxy-3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]propyl] (9Z,12Z)-hexadeca-9,12-dienoate

C51H84O5 (776.6318)

[3-octanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] pentacosanoate

C49H92O6 (776.6894)

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C51H84O5 (776.6318)

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C51H84O5 (776.6318)

[2-[(Z)-heptadec-9-enoyl]oxy-3-octanoyloxypropyl] henicosanoate

C49H92O6 (776.6894)

(2-octadecanoyloxy-3-octanoyloxypropyl) (Z)-icos-11-enoate

C49H92O6 (776.6894)

[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C51H84O5 (776.6318)

[2-[(Z)-hexadec-9-enoyl]oxy-3-nonanoyloxypropyl] henicosanoate

C49H92O6 (776.6894)

[2-dodecanoyloxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propyl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C51H84O5 (776.6318)

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-[(Z)-tetradec-9-enoxy]propyl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C51H84O5 (776.6318)

[3-decoxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropyl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C51H84O5 (776.6318)

[2-decanoyloxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propyl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C51H84O5 (776.6318)

(2-hexadecanoyloxy-3-nonanoyloxypropyl) (Z)-henicos-11-enoate

C49H92O6 (776.6894)

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hexadecoxypropyl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C51H84O5 (776.6318)

[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C51H84O5 (776.6318)

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]propyl] (9Z,12Z)-hexadeca-9,12-dienoate

C51H84O5 (776.6318)

[2-decanoyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propyl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C51H84O5 (776.6318)

[3-nonanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] tricosanoate

C49H92O6 (776.6894)

[2-dodecanoyloxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C51H84O5 (776.6318)

(2-dodecanoyloxy-3-octanoyloxypropyl) (Z)-hexacos-15-enoate

C49H92O6 (776.6894)

(3-nonanoyloxy-2-pentadecanoyloxypropyl) (Z)-docos-13-enoate

C49H92O6 (776.6894)

(2-heptadecanoyloxy-3-octanoyloxypropyl) (Z)-henicos-11-enoate

C49H92O6 (776.6894)

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-tetradecoxypropyl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C51H84O5 (776.6318)

[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C51H84O5 (776.6318)

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(Z)-tetradec-9-enoxy]propyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C51H84O5 (776.6318)

[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-tetradecanoyloxypropyl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C51H84O5 (776.6318)

(3-nonanoyloxy-2-undecanoyloxypropyl) (Z)-hexacos-15-enoate

C49H92O6 (776.6894)

[2-decanoyloxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propyl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C51H84O5 (776.6318)

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropan-2-yl] hexadecanoate

C51H84O5 (776.6318)

[3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]-2-tetradecanoyloxypropyl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C51H84O5 (776.6318)

[3-decoxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropyl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C51H84O5 (776.6318)

[3-nonanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] nonadecanoate

C49H92O6 (776.6894)

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-[(Z)-tetradec-9-enoxy]propyl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C51H84O5 (776.6318)

[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C51H84O5 (776.6318)

[2-[(Z)-octadec-9-enoyl]oxy-3-octanoyloxypropyl] icosanoate

C49H92O6 (776.6894)

[3-octanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] tricosanoate

C49H92O6 (776.6894)

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] (Z)-hexadec-9-enoate

C51H84O5 (776.6318)

[3-dodecoxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropyl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C51H84O5 (776.6318)

[2-decanoyloxy-3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoxy]propyl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C51H84O5 (776.6318)

[2-dodecanoyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propyl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C51H84O5 (776.6318)

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C51H84O5 (776.6318)

(2-heptadecanoyloxy-3-nonanoyloxypropyl) (Z)-icos-11-enoate

C49H92O6 (776.6894)

[3-nonanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] tetracosanoate

C49H92O6 (776.6894)

(3-nonanoyloxy-2-tridecanoyloxypropyl) (Z)-tetracos-13-enoate

C49H92O6 (776.6894)

[2-decanoyloxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propyl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C51H84O5 (776.6318)

(2-decanoyloxy-3-octanoyloxypropyl) (Z)-octacos-17-enoate

C49H92O6 (776.6894)

[2-dodecanoyloxy-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]propyl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C51H84O5 (776.6318)

[2-decanoyloxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C51H84O5 (776.6318)

[3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C51H84O5 (776.6318)

[3-decoxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropyl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C51H84O5 (776.6318)

[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C51H84O5 (776.6318)

[2-decanoyloxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propyl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C51H84O5 (776.6318)

(3-octanoyloxy-2-tetradecanoyloxypropyl) (Z)-tetracos-13-enoate

C49H92O6 (776.6894)

[1-[(Z)-nonadec-9-enoyl]oxy-3-octanoyloxypropan-2-yl] nonadecanoate

C49H92O6 (776.6894)

[2-dodecanoyloxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C51H84O5 (776.6318)

[3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] (9Z,12Z)-hexadeca-9,12-dienoate

C51H84O5 (776.6318)

[2-decanoyloxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]propyl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C51H84O5 (776.6318)

[1-dodecoxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C51H84O5 (776.6318)

(2-hexadecanoyloxy-3-octanoyloxypropyl) (Z)-docos-13-enoate

C49H92O6 (776.6894)

[3-dodecoxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropyl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C51H84O5 (776.6318)

[3-decoxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropyl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C51H84O5 (776.6318)

[2-decanoyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propyl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C51H84O5 (776.6318)

[2-dodecanoyloxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]propyl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C51H84O5 (776.6318)

[3-octanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] tetracosanoate

C49H92O6 (776.6894)

[2-decanoyloxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propyl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C51H84O5 (776.6318)

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-tetradecoxypropyl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C51H84O5 (776.6318)

[3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C51H84O5 (776.6318)

(3-decanoyloxy-2-pentadecanoyloxypropyl) (Z)-henicos-11-enoate

C49H92O6 (776.6894)

[3-decanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] henicosanoate

C49H92O6 (776.6894)

[3-dodecanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] octadecanoate

C49H92O6 (776.6894)

(3-decanoyloxy-2-tetradecanoyloxypropyl) (Z)-docos-13-enoate

C49H92O6 (776.6894)

[2-[(Z)-hexadec-9-enoyl]oxy-3-tridecanoyloxypropyl] heptadecanoate

C49H92O6 (776.6894)

(2-pentadecanoyloxy-3-tridecanoyloxypropyl) (Z)-octadec-9-enoate

C49H92O6 (776.6894)

[3-dodecanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] henicosanoate

C49H92O6 (776.6894)

(3-decanoyloxy-2-heptadecanoyloxypropyl) (Z)-nonadec-9-enoate

C49H92O6 (776.6894)

(2-pentadecanoyloxy-3-tetradecanoyloxypropyl) (Z)-heptadec-9-enoate

C49H92O6 (776.6894)

(2-hexadecanoyloxy-3-tridecanoyloxypropyl) (Z)-heptadec-9-enoate

C49H92O6 (776.6894)

(3-dodecanoyloxy-2-tridecanoyloxypropyl) (Z)-henicos-11-enoate

C49H92O6 (776.6894)

[2-[(Z)-tetradec-9-enoyl]oxy-3-undecanoyloxypropyl] henicosanoate

C49H92O6 (776.6894)

[1-[(Z)-hexadec-9-enoyl]oxy-3-tetradecanoyloxypropan-2-yl] hexadecanoate

C49H92O6 (776.6894)

(3-dodecanoyloxy-2-hexadecanoyloxypropyl) (Z)-octadec-9-enoate

C49H92O6 (776.6894)

[3-decanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] icosanoate

C49H92O6 (776.6894)

2,3-di(decanoyloxy)propyl (Z)-hexacos-15-enoate

C49H92O6 (776.6894)

[3-tridecanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] icosanoate

C49H92O6 (776.6894)

(2-heptadecanoyloxy-3-undecanoyloxypropyl) (Z)-octadec-9-enoate

C49H92O6 (776.6894)

[2-pentadecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] octadecanoate

C49H92O6 (776.6894)

2,3-di(dodecanoyloxy)propyl (Z)-docos-13-enoate

C49H92O6 (776.6894)

(3-decanoyloxy-2-hexadecanoyloxypropyl) (Z)-icos-11-enoate

C49H92O6 (776.6894)

[2-[(Z)-pentadec-9-enoyl]oxy-3-undecanoyloxypropyl] icosanoate

C49H92O6 (776.6894)

[3-decanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] nonadecanoate

C49H92O6 (776.6894)

2,3-di(undecanoyloxy)propyl (Z)-tetracos-13-enoate

C49H92O6 (776.6894)

(2-tridecanoyloxy-3-undecanoyloxypropyl) (Z)-docos-13-enoate

C49H92O6 (776.6894)

[3-decanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] docosanoate

C49H92O6 (776.6894)

(2-tetradecanoyloxy-3-undecanoyloxypropyl) (Z)-henicos-11-enoate

C49H92O6 (776.6894)

[2-tetradecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] nonadecanoate

C49H92O6 (776.6894)

(2-pentadecanoyloxy-3-undecanoyloxypropyl) (Z)-icos-11-enoate

C49H92O6 (776.6894)

[2-[(Z)-hexadec-9-enoyl]oxy-3-undecanoyloxypropyl] nonadecanoate

C49H92O6 (776.6894)

(3-decanoyloxy-2-dodecanoyloxypropyl) (Z)-tetracos-13-enoate

C49H92O6 (776.6894)

[2-[(Z)-tridec-9-enoyl]oxy-3-undecanoyloxypropyl] docosanoate

C49H92O6 (776.6894)

[1-decanoyloxy-3-[(Z)-octadec-9-enoyl]oxypropan-2-yl] octadecanoate

C49H92O6 (776.6894)

[1-dodecanoyloxy-3-[(Z)-heptadec-9-enoyl]oxypropan-2-yl] heptadecanoate

C49H92O6 (776.6894)

[3-decanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] tricosanoate

C49H92O6 (776.6894)

[2-[(Z)-heptadec-9-enoyl]oxy-3-undecanoyloxypropyl] octadecanoate

C49H92O6 (776.6894)

[2-hexadecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] heptadecanoate

C49H92O6 (776.6894)

(2-hexadecanoyloxy-3-undecanoyloxypropyl) (Z)-nonadec-9-enoate

C49H92O6 (776.6894)

2,3-di(pentadecanoyloxy)propyl (Z)-hexadec-9-enoate

C49H92O6 (776.6894)

[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-hydroxypropyl] (15Z,18Z)-hexacosa-15,18-dienoate

C51H84O5 (776.6318)

[1-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-hydroxypropan-2-yl] (14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoate

C51H84O5 (776.6318)

[3-hydroxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropyl] (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate

C51H84O5 (776.6318)

[3-dodecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] nonadecanoate

C49H92O6 (776.6894)

2,3-di(tridecanoyloxy)propyl (Z)-icos-11-enoate

C49H92O6 (776.6894)

[2-[(Z)-pentadec-9-enoyl]oxy-3-tridecanoyloxypropyl] octadecanoate

C49H92O6 (776.6894)

(3-dodecanoyloxy-2-tetradecanoyloxypropyl) (Z)-icos-11-enoate

C49H92O6 (776.6894)

[3-pentadecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] hexadecanoate

C49H92O6 (776.6894)

[3-dodecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] icosanoate

C49H92O6 (776.6894)

[2-hexadecanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] hexadecanoate

C49H92O6 (776.6894)

(2-tetradecanoyloxy-3-tridecanoyloxypropyl) (Z)-nonadec-9-enoate

C49H92O6 (776.6894)

[2-[(Z)-pentadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] heptadecanoate

C49H92O6 (776.6894)

[2-pentadecanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] heptadecanoate

C49H92O6 (776.6894)

(3-dodecanoyloxy-2-pentadecanoyloxypropyl) (Z)-nonadec-9-enoate

C49H92O6 (776.6894)

[3-tetradecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] octadecanoate

C49H92O6 (776.6894)

[2-[(Z)-tetradec-9-enoyl]oxy-3-tridecanoyloxypropyl] nonadecanoate

C49H92O6 (776.6894)

[3-dodecanoyloxy-2-[(Z)-hexadec-7-enoyl]oxypropyl] octadecanoate

C49H92O6 (776.6894)

[2-[(Z)-hexadec-7-enoyl]oxy-3-tridecanoyloxypropyl] heptadecanoate

C49H92O6 (776.6894)

[3-tridecanoyloxy-2-[(Z)-tridec-8-enoyl]oxypropyl] icosanoate

C49H92O6 (776.6894)

2,3-di(dodecanoyloxy)propyl (Z)-docos-11-enoate

C49H92O6 (776.6894)

[3-[(Z)-dodec-5-enoyl]oxy-2-hexadecanoyloxypropyl] octadecanoate

C49H92O6 (776.6894)

(3-dodecanoyloxy-2-tridecanoyloxypropyl) (Z)-henicos-9-enoate

C49H92O6 (776.6894)

[3-dodecanoyloxy-2-[(Z)-dodec-5-enoyl]oxypropyl] docosanoate

C49H92O6 (776.6894)

[2-hexadecanoyloxy-3-[(Z)-tridec-8-enoyl]oxypropyl] heptadecanoate

C49H92O6 (776.6894)

[3-[(Z)-dodec-5-enoyl]oxy-2-tridecanoyloxypropyl] henicosanoate

C49H92O6 (776.6894)

[1-dodecanoyloxy-3-[(Z)-heptadec-7-enoyl]oxypropan-2-yl] heptadecanoate

C49H92O6 (776.6894)

[1-[(Z)-hexadec-7-enoyl]oxy-3-tetradecanoyloxypropan-2-yl] hexadecanoate

C49H92O6 (776.6894)

[3-[(Z)-dodec-5-enoyl]oxy-2-tetradecanoyloxypropyl] icosanoate

C49H92O6 (776.6894)

(2-pentadecanoyloxy-3-tridecanoyloxypropyl) (Z)-octadec-11-enoate

C49H92O6 (776.6894)

[3-[(Z)-dodec-5-enoyl]oxy-2-heptadecanoyloxypropyl] heptadecanoate

C49H92O6 (776.6894)

[3-[(Z)-dodec-5-enoyl]oxy-2-pentadecanoyloxypropyl] nonadecanoate

C49H92O6 (776.6894)

[2-tetradecanoyloxy-3-[(Z)-tridec-8-enoyl]oxypropyl] nonadecanoate

C49H92O6 (776.6894)

(2-pentadecanoyloxy-3-tetradecanoyloxypropyl) (Z)-heptadec-7-enoate

C49H92O6 (776.6894)

[2-pentadecanoyloxy-3-[(Z)-tridec-8-enoyl]oxypropyl] octadecanoate

C49H92O6 (776.6894)

2,3-di(tetradecanoyloxy)propyl (Z)-octadec-11-enoate

C49H92O6 (776.6894)

[3-dodecanoyloxy-2-[(Z)-tridec-8-enoyl]oxypropyl] henicosanoate

C49H92O6 (776.6894)

2,3-di(pentadecanoyloxy)propyl (Z)-hexadec-7-enoate

C49H92O6 (776.6894)

(3-dodecanoyloxy-2-hexadecanoyloxypropyl) (Z)-octadec-11-enoate

C49H92O6 (776.6894)

(2-hexadecanoyloxy-3-tridecanoyloxypropyl) (Z)-heptadec-7-enoate

C49H92O6 (776.6894)

2-[Hydroxy-(2-octadecanoyloxy-3-octadecoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[(3-Hexadecoxy-2-icosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[(2-Docosanoyloxy-3-tetradecoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[(2-Hexadecanoyloxy-3-icosoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

[1-carboxy-3-[3-dodecanoyloxy-2-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(14E,16E)-docosa-14,16-dienoyl]oxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxy-2-tridecanoyloxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxy-2-tricosanoyloxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(E)-nonadec-9-enoyl]oxy-3-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(7E,9E)-tetradeca-7,9-dienoyl]oxy-2-[(E)-tricos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(7E,9E)-tetradeca-7,9-dienoyl]oxy-3-[(E)-tricos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxy-2-octadecanoyloxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(E)-pentacos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxy-2-undecanoyloxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(11E,14E)-hexacosa-11,14-dienoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-heptadecanoyloxy-2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-docosanoyloxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[(2S)-3-hydroxy-2-[(5E,8E,11E,14E)-tetracosa-5,8,11,14-tetraenoyl]oxypropyl] (5E,8E,11E,14E)-tetracosa-5,8,11,14-tetraenoate

C51H84O5 (776.6318)

[1-carboxy-3-[3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-2-icosanoyloxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-2-pentadecanoyloxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-dodecanoyloxy-3-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-pentacosanoyloxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(E)-nonadec-9-enoyl]oxy-2-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[(2R)-1-[(E)-hexadec-9-enoyl]oxy-3-tetradecanoyloxypropan-2-yl] hexadecanoate

C49H92O6 (776.6894)

[1-carboxy-3-[3-[(9E,11E)-henicosa-9,11-dienoyl]oxy-2-[(E)-hexadec-7-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(9E,11E)-henicosa-9,11-dienoyl]oxy-3-[(E)-hexadec-7-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(18E,21E)-tetracosa-18,21-dienoyl]oxy-3-[(E)-tridec-8-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-2-hexadecanoyloxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-2-[(E)-icos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(E)-docos-11-enoyl]oxy-2-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-3-[(E)-icos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-pentacosanoyloxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(11E,14E)-hexacosa-11,14-dienoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(E)-docos-11-enoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(14E,16E)-docosa-14,16-dienoyl]oxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(E)-dodec-5-enoyl]oxy-3-[(11E,14E)-pentacosa-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-docosanoyloxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-tetradecanoyloxy-2-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[(2S)-1-[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-hydroxypropan-2-yl] (5E,9E)-hexacosa-5,9-dienoate

C51H84O5 (776.6318)

[1-carboxy-3-[3-[(E)-dodec-5-enoyl]oxy-2-[(11E,14E)-pentacosa-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-nonadecanoyloxy-3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(E)-henicos-9-enoyl]oxy-3-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(7E,9E)-nonadeca-7,9-dienoyl]oxy-2-[(E)-octadec-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-tetradecanoyloxy-3-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-3-hexadecanoyloxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxy-3-tricosanoyloxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-henicosanoyloxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(E)-heptadec-7-enoyl]oxy-3-[(11E,14E)-icosa-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(E)-heptadec-7-enoyl]oxy-2-[(11E,14E)-icosa-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxy-3-octadecanoyloxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-3-pentadecanoyloxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(7E,9E)-nonadeca-7,9-dienoyl]oxy-3-[(E)-octadec-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(E)-tetradec-9-enoyl]oxy-2-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-henicosanoyloxy-3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxy-3-undecanoyloxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[(2S)-2-[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-hydroxypropyl] (5E,9E)-hexacosa-5,9-dienoate

C51H84O5 (776.6318)

[1-carboxy-3-[2-[(E)-tetradec-9-enoyl]oxy-3-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(18E,21E)-tetracosa-18,21-dienoyl]oxy-2-[(E)-tridec-8-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-nonadecanoyloxy-2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxy-3-tridecanoyloxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(E)-henicos-9-enoyl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(E)-pentacos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-3-icosanoyloxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-heptadecanoyloxy-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-heptadecanoyloxy-2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(Z)-nonadec-9-enoyl]oxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(Z)-henicos-11-enoyl]oxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-[(Z)-icos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-nonadecanoyloxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-henicosanoyloxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-pentadecanoyloxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

[1-carboxy-3-[3-[(Z)-heptadec-9-enoyl]oxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium

C47H86NO7+ (776.6404)

2-[Hydroxy-(2-octacosanoyloxy-3-octoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[(3-Hexatriacontanoyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[Hydroxy-(2-tricosanoyloxy-3-tridecoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[Hydroxy-(3-octacosoxy-2-octanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[(2-Heptadecanoyloxy-3-nonadecoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[(3-Decoxy-2-hexacosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[(3-Henicosoxy-2-pentadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[(3-Dodecoxy-2-tetracosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[(3-Heptacosoxy-2-nonanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[(2-Heptacosanoyloxy-3-nonoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[(3-Heptadecoxy-2-nonadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[(3-Docosoxy-2-tetradecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[(2-Decanoyloxy-3-hexacosoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[(2-Henicosanoyloxy-3-pentadecoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[(2-Dodecanoyloxy-3-tetracosoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[Hydroxy-(3-tricosoxy-2-tridecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[Hydroxy-(3-pentacosoxy-2-undecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

2-[Hydroxy-(2-pentacosanoyloxy-3-undecoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C44H91NO7P+ (776.6533)

Dextrothyroxine

C15H11I4NO4 (776.6867)

C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1553 - Thyroid Agent D-Thyroxine (D-T4) is a thyroid hormone that can inhibit TSH secretion. D-Thyroxine can be used for the research of hypercholesterolemia[1][2].

DL-Thyroxine

C15H11I4NO4 (776.6867)

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1553 - Thyroid Agent

L-thyroxine zwitterion

C15H11I4NO4 (776.6867)

Zwitterionic form of L-thyroxine.

triacylglycerol 46:1

C49H92O6 (776.6894)

A triglyceride in which the three acyl groups contain a total of 46 carbons and 1 double bond.

NA-Orn 43:1

C48H92N2O5 (776.7006)

FAHFA 26:0/O-26:7

C52H88O4 (776.6682)

FAHFA 26:1/O-26:6

C52H88O4 (776.6682)

FAHFA 26:2/O-26:5

C52H88O4 (776.6682)

FAHFA 26:3/O-26:4

C52H88O4 (776.6682)

FAHFA 26:4/O-26:3

C52H88O4 (776.6682)

FAHFA 26:5/O-26:2

C52H88O4 (776.6682)

FAHFA 26:6/O-26:1

C52H88O4 (776.6682)

FAHFA 26:7/O-26:0

C52H88O4 (776.6682)

FAHFA 52:7;O

C52H88O4 (776.6682)

DG 22:6_26:2

C51H84O5 (776.6318)

DG 24:4_24:4

C51H84O5 (776.6318)

DG 48:8

C51H84O5 (776.6318)

TG 10:0_10:0_26:1

C49H92O6 (776.6894)

TG 10:0_12:0_24:1

C49H92O6 (776.6894)

TG 10:0_14:0_22:1

C49H92O6 (776.6894)

TG 10:0_14:1_22:0

C49H92O6 (776.6894)

TG 10:0_15:1_21:0

C49H92O6 (776.6894)

TG 10:0_16:0_20:1

C49H92O6 (776.6894)

TG 10:0_16:1_20:0

C49H92O6 (776.6894)

TG 10:0_17:1_19:0

C49H92O6 (776.6894)

TG 10:0_18:0_18:1

C49H92O6 (776.6894)

TG 11:0_11:0_24:1

C49H92O6 (776.6894)

TG 11:0_13:0_22:1

C49H92O6 (776.6894)

TG 11:0_14:1_21:0

C49H92O6 (776.6894)

TG 11:0_15:0_20:1

C49H92O6 (776.6894)

TG 11:0_15:1_20:0

C49H92O6 (776.6894)

TG 11:0_16:1_19:0

C49H92O6 (776.6894)

TG 11:0_17:0_18:1

C49H92O6 (776.6894)

TG 11:0_17:1_18:0

C49H92O6 (776.6894)

TG 12:0_12:0_22:1

C49H92O6 (776.6894)

TG 12:0/12:0/22:1(11Z)

C49H92O6 (776.6894)

TG 12:0_14:0_20:1

C49H92O6 (776.6894)

TG 12:0_14:1_20:0

C49H92O6 (776.6894)

TG 12:0_15:1_19:0

C49H92O6 (776.6894)

TG(12:0/16:0/18:1)

C49H92O6 (776.6894)

TG 12:0_16:1_18:0

C49H92O6 (776.6894)

TG 12:0_17:0_17:1

C49H92O6 (776.6894)

TG 12:1_16:0_18:0

C49H92O6 (776.6894)

TG 13:0_13:0_20:1

C49H92O6 (776.6894)

TG 13:0_14:1_19:0

C49H92O6 (776.6894)

TG 13:0_15:0_18:1

C49H92O6 (776.6894)

TG 13:0_15:1_18:0

C49H92O6 (776.6894)

TG 13:0_16:0_17:1

C49H92O6 (776.6894)

TG 13:0_16:1_17:0

C49H92O6 (776.6894)

TG 14:0_14:0_18:1

C49H92O6 (776.6894)

TG 14:0_14:1_18:0

C49H92O6 (776.6894)

TG 14:0_15:0_17:1

C49H92O6 (776.6894)

TG 14:0_15:1_17:0

C49H92O6 (776.6894)

TG 14:0_16:0_16:1

C49H92O6 (776.6894)

TG 14:0/16:0/16:1

C49H92O6 (776.6894)

TG 14:1_15:0_17:0

C49H92O6 (776.6894)

TG 14:1_16:0_16:0

C49H92O6 (776.6894)

TG 15:0_15:0_16:1

C49H92O6 (776.6894)

TG 15:0_15:1_16:0

C49H92O6 (776.6894)

TG 16:0/14:0/16:1

C49H92O6 (776.6894)

TG 46:1_12:0

C49H92O6 (776.6894)

TG 46:1_14:0

C49H92O6 (776.6894)

TG 46:1_14:1

C49H92O6 (776.6894)

TG 46:1_15:0

C49H92O6 (776.6894)

TG 46:1_16:0

C49H92O6 (776.6894)

TG 46:1_16:1

C49H92O6 (776.6894)

TG 46:1_17:0

C49H92O6 (776.6894)

TG 46:1_18:0

C49H92O6 (776.6894)

TG 46:1_18:1

C49H92O6 (776.6894)

TG 46:1_20:0

C49H92O6 (776.6894)

TG 46:1_20:1

C49H92O6 (776.6894)

TG 46:1_22:1

C49H92O6 (776.6894)

CerPE 15:0;O2/26:0;O

C43H89N2O7P (776.6407)

CerPE 16:0;O2/25:0;O

C43H89N2O7P (776.6407)

CerPE 17:0;O2/24:0;O

C43H89N2O7P (776.6407)

CerPE 18:0;O2/23:0;O

C43H89N2O7P (776.6407)

CerPE 19:0;O2/22:0;O

C43H89N2O7P (776.6407)

CerPE 20:0;O2/21:0;O

C43H89N2O7P (776.6407)

CerPE 21:0;O2/20:0;O

C43H89N2O7P (776.6407)

CerPE 22:0;O2/19:0;O

C43H89N2O7P (776.6407)

CerPE 41:0;O2;O

C43H89N2O7P (776.6407)

SM 14:0;O2/24:0;O

C43H89N2O7P (776.6407)

SM 15:0;O2/23:0;O

C43H89N2O7P (776.6407)

SM 16:0;O2/22:0;O

C43H89N2O7P (776.6407)

SM 17:0;O2/21:0;O

C43H89N2O7P (776.6407)

SM 18:0;O2/20:0;O

C43H89N2O7P (776.6407)

SM 19:0;O2/19:0;O

C43H89N2O7P (776.6407)

SM 20:0;O2/18:0;O

C43H89N2O7P (776.6407)

SM 21:0;O2/17:0;O

C43H89N2O7P (776.6407)

SM 22:0;O2/16:0;O

C43H89N2O7P (776.6407)

SM 38:0;O2;O

C43H89N2O7P (776.6407)